Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Evans

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Iscience|July 24, 2025
Adaptive <i>PRKAA1</i> variant in Andeans is associated with improved ventilation and sleep phenotypesElijah S Lawrence, Wanjun Gu, Mitchell C Kong, et al.
Lancet (London, England)|September 21, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trialChantal Mathieu, Julie Wych, A Emile J Hendriks, et al.
The Journal of Bone and Joint Surgery. American Volume|November 22, 2016
The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on: Management of Carpal Tunnel SyndromeBrent Graham, Allan E Peljovich, Robert Afra, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Plos Medicine|October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A Todd, Marina Evangelou, Antony J Cutler, et al.
The New England Journal of Medicine|June 9, 2016
Exome Sequencing and the Management of Neurometabolic DisordersMaja Tarailo-Graovac, Casper Shyr, Colin J Ross, et al.
Nucleic Acids Research|November 14, 2022
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Arpad M Danos, Jason Saliba, et al.
Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Iscience|July 24, 2025
Adaptive <i>PRKAA1</i> variant in Andeans is associated with improved ventilation and sleep phenotypesElijah S Lawrence, Wanjun Gu, Mitchell C Kong, et al.
Lancet (London, England)|September 21, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trialChantal Mathieu, Julie Wych, A Emile J Hendriks, et al.
The Journal of Bone and Joint Surgery. American Volume|November 22, 2016
The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on: Management of Carpal Tunnel SyndromeBrent Graham, Allan E Peljovich, Robert Afra, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Plos Medicine|October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A Todd, Marina Evangelou, Antony J Cutler, et al.
The New England Journal of Medicine|June 9, 2016
Exome Sequencing and the Management of Neurometabolic DisordersMaja Tarailo-Graovac, Casper Shyr, Colin J Ross, et al.
Nucleic Acids Research|November 14, 2022
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Arpad M Danos, Jason Saliba, et al.
Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.
Pageof 23